Meek David D.
CIK: 0001555337•Chief Executive Officer
OfficerDirector
Primary company: uniQure N.V. (QURE)
Meek David D. is a corporate insider (Chief Executive Officer) at uniQure N.V. (QURE) filing SEC Form 4 transactions. 70 transactions across 7 companies, totaling $0 in purchases and $642,925 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
uniQure N.V. QURE | Sale | 2,112 | $14.45 | $31K | 34,190 | 6/20/2025 Filed: 6/24/2025 | Filing → |
| Award | 38,513 | - | - | 38,513 | 6/12/2025 Filed: 6/16/2025 | Filing → | |
uniQure N.V. QURE | Award | 15,630 | - | - | 15,630 | 6/11/2025 Filed: 6/13/2025 | Filing → |
uniQure N.V. QURE | Award | 7,970 | - | - | 36,302 | 6/11/2025 Filed: 6/13/2025 | Filing → |
uniQure N.V. QURE | Award | 15,840 | - | - | 15,840 | 6/19/2024 Filed: 6/21/2024 | Filing → |
uniQure N.V. QURE | Award | 8,080 | - | - | 28,332 | 6/19/2024 Filed: 6/21/2024 | Filing → |
uniQure N.V. QURE | Sale | 2,229 | $5.12 | $11K | 20,252 | 6/13/2024 Filed: 6/17/2024 | Filing → |
Fusion Pharmaceuticals Inc. FUSN | Disposition | 34,000 | - | - | 0 | 6/4/2024 Filed: 6/4/2024 | Filing → |
| Award | 15,618 | - | - | 15,618 | 5/15/2024 Filed: 5/16/2024 | Filing → | |
Fusion Pharmaceuticals Inc. FUSN | Award | 34,000 | $0.00 | $0 | 34,000 | 10/16/2023 Filed: 10/16/2023 | Filing → |
uniQure N.V. QURE | Sale | 2,290 | $18.85 | $43K | 22,481 | 6/16/2023 Filed: 6/20/2023 | Filing → |
uniQure N.V. QURE | Award | 17,060 | $0.00 | $0 | 17,060 | 6/13/2023 Filed: 6/20/2023 | Filing → |
uniQure N.V. QURE | Award | 8,700 | $0.00 | $0 | 24,771 | 6/13/2023 Filed: 6/20/2023 | Filing → |
uniQure N.V. QURE | Sale | 389 | $19.71 | $8K | 16,071 | 2/27/2023 Filed: 3/1/2023 | Filing → |
Mirati Therapeutics, Inc. MRTX | Award | 151,233 | $0.00 | $0 | 151,233 | 1/20/2023 Filed: 1/24/2023 | Filing → |
Mirati Therapeutics, Inc. MRTX | Award | 89,379 | $0.00 | $0 | 151,171 | 1/20/2023 Filed: 1/24/2023 | Filing → |
Mirati Therapeutics, Inc. MRTX | Sale | 3,179 | $42.38 | $135K | 61,792 | 1/17/2023 Filed: 1/19/2023 | Filing → |
Mirati Therapeutics, Inc. MRTX | Sale | 4,616 | $40.41 | $187K | 64,971 | 12/21/2022 Filed: 12/21/2022 | Filing → |
Mirati Therapeutics, Inc. MRTX | Award | 35,425 | $0.00 | $0 | 69,587 | 12/19/2022 Filed: 12/21/2022 | Filing → |
Entasis Therapeutics Holdings Inc. ETTX | J | 11,000 | $0.00 | $0 | 0 | 7/11/2022 Filed: 7/11/2022 | Filing → |
uniQure N.V.
QURE
Type
Sale
Shares
2,112
Price
$14.45
Value
$31K
Type
Award
Shares
38,513
Price
-
Value
-
uniQure N.V.
QURE
Type
Award
Shares
15,630
Price
-
Value
-
uniQure N.V.
QURE
Type
Award
Shares
7,970
Price
-
Value
-
uniQure N.V.
QURE
Type
Award
Shares
15,840
Price
-
Value
-
uniQure N.V.
QURE
Type
Award
Shares
8,080
Price
-
Value
-
uniQure N.V.
QURE
Type
Sale
Shares
2,229
Price
$5.12
Value
$11K
Fusion Pharmaceuticals Inc.
FUSN
Type
Disposition
Shares
34,000
Price
-
Value
-
Type
Award
Shares
15,618
Price
-
Value
-
Fusion Pharmaceuticals Inc.
FUSN
Type
Award
Shares
34,000
Price
$0.00
Value
$0
uniQure N.V.
QURE
Type
Sale
Shares
2,290
Price
$18.85
Value
$43K
uniQure N.V.
QURE
Type
Award
Shares
17,060
Price
$0.00
Value
$0
uniQure N.V.
QURE
Type
Award
Shares
8,700
Price
$0.00
Value
$0
uniQure N.V.
QURE
Type
Sale
Shares
389
Price
$19.71
Value
$8K
Mirati Therapeutics, Inc.
MRTX
Type
Award
Shares
151,233
Price
$0.00
Value
$0
Mirati Therapeutics, Inc.
MRTX
Type
Award
Shares
89,379
Price
$0.00
Value
$0
Mirati Therapeutics, Inc.
MRTX
Type
Sale
Shares
3,179
Price
$42.38
Value
$135K
Mirati Therapeutics, Inc.
MRTX
Type
Sale
Shares
4,616
Price
$40.41
Value
$187K
Mirati Therapeutics, Inc.
MRTX
Type
Award
Shares
35,425
Price
$0.00
Value
$0
Entasis Therapeutics Holdings Inc.
ETTX
Type
J
Shares
11,000
Price
$0.00
Value
$0
AI Agent
Try asking...